Navigation Links
AOTI Inc. Announces New York City Office Grand Opening
Date:8/15/2017

OCEANSIDE, Calif., Aug. 15, 2017 /PRNewswire/ -- AOTI Inc. announced today that its fully owned USA-operating subsidiary, Advanced Oxygen Therapy Inc., has recently opened a New York City Office in Yonkers, New York to support the ever-increasing usage of its unique Topical Wound Oxygen (TWO2) homecare therapy. This new East Coast location has also been approved by the Accreditation Commission for Health Care (ACHC) under the company's DMEPOS accreditation for Home/Durable Medical Equipment Services.

Advanced Oxygen Therapy Inc. New York Team at the New York City Office Grand Opening
Advanced Oxygen Therapy Inc. New York Team at the New York City Office Grand Opening

"We are absolutely delighted to be opening our first DMEPOS accredited East Coast hub that is a natural evolution for our growing company and will allow for our unique Topical Wound Oxygen (TWO2) therapy to be provided even more seamlessly to Veterans Affairs (VA), Medicaid and Medicare patients moving forward," stated Dr. Mike Griffiths, CEO and President of AOTI.

Additionally, AOTI Inc. announced that its Diamond Sponsorship of the 2017 PRESENT Podiatric Residency Education Summit in Teaneck, New Jersey, held this past weekend, had been a great success, with both lectures and workshops highlighting the significant clinical benefits of TWO2 therapy being packed close to capacity.

Dr. Griffiths added "AOTI is dedicated to developing the strongest scientific evidence to support the healing and health economic outcomes achieved by our unique TWO2 homecare therapy. Such targeted events as these allow dedicated wound care physicians to receive both evidence based education, along with invaluable hands-on experience in the use of our patented therapy."

About AOTI
AOTI Inc. is a leading international company providing innovative solutions to resolve severe and chronic wounds worldwide. Our products reduce healthcare costs and improve the quality of life for patients with these debilitating illnesses. Our patented non-invasive Topical Wound Oxygen (TWO2) therapy is unsurpassed in fully closing Diabetic, Venous and Pressure ulcers alike. AOTI is a private company based in Oceanside, California USA and Galway, Ireland with offices throughout the globe. For more information, see: www.aotinc.net

Dr. Mike Griffiths
CEO and President
172174@email4pr.com 
(760) 672 1920             

View original content with multimedia:http://www.prnewswire.com/news-releases/aoti-inc-announces-new-york-city-office-grand-opening-300504376.html


'/>"/>
SOURCE AOTI Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Pharmagen Announces First Quarter 2013 Results
2. Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Third Quarter Of 2013 Fiscal Year
3. Vasomedical Announces Financial Results for the First Quarter of 2013
4. TSI Announces 2013 Respiratory Protection Roadshow Training Dates and Locations
5. Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeants Board of Directors
6. Active Life Announces $500K Follow On Series A Investment - Tech Coast Angels Re-up
7. Pentec Health Announces Limited Voluntary Recall of Certain Compounded Prescription Therapies for Renal Patients
8. DebMed Announces US Patent
9. Physician-Patient Alliance for Health & Safety Announces Four Essentials for Safety for Patients Receiving Opioids
10. Lakewood-Amedex Announces Results Demonstrating The More Rapid Direct Bactericidal Activity Of Novel Bisphosphocin Class Of Antimicrobials
11. OrthoView Announces the U.S. Launch of a New, Subscription-based, Digital Planning and Templating Solution for Individual Orthopaedic Surgeons
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... their devotion to personalized service, SMP Pharmacy Solutions announces their ... South Florida Business Journal,s 50 Fastest-Growing Companies, and listed for ... specialty pharmacy has found its niche.  To that end, the ... by SFBJ as the 2017 Power Leader in Health Care. ... award in October, Bardisa said of the three achievements, "It,s ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/19/2017)... Ky. , Sept. 19, 2017   ZirMed Inc ... predictive analytics, today announced that it has been ranked #1 ... Black Book™ Rankings 2017 User Survey. ZirMed was ... solution for large hospitals and medical centers over 200 beds ... Black Book,s healthcare technology user survey history. ...
Breaking Medicine Technology:
(Date:10/13/2017)... VA (PRWEB) , ... October 13, 2017 , ... ... of DevOps and Agile Software Development, has been awarded a contract by the ... Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
Breaking Medicine News(10 mins):